WCMNY
CERE

Westchester Capital Management (New York)’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Westchester Capital Management (New York)’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-793,349
Closed -$32.4M – 230
2024
Q2 		$32.4M Buy
793,349
+45,755
+6% +$1.87M 1.22% 20
2024
Q1 		$31.6M Buy
747,594
+18,284
+3% +$773K 1.16% 17
2023
Q4 		$30.9M Buy
+729,310
New +$30.9M 1.08% 19